KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Kymera Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$108.07+3.29 (+3.14%)
Close on Oct 19, 2026
- Market cap
- $10.61B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Kymera Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 27, 2025 | Sep 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2024 | Aug 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |